Descripción de negocio
The Siegfried Group is a global life sciences company with facilities located in Switzerland, the USA, Malta, China, Germany and France. Siegfried is active in primary and secondary drug manufacturing. The company develops and manufactures active pharmaceutical ingredients for pharmaceutical clients with R& D programs, related intermediates and controlled substances. Siegfried also offers development and production of finished dosage forms, including sterile fillings.
Consejo de gestión & Consejo de supervisión
| CEO |
| Dr. Wolfgang Wienand |
| Consejo de gestión |
| Dr. Reto Suter, Dr. Jürgen Roos, Irene Wosgien, Marcel Imwinkelried, Marianne Späne, Henrik Krüpper, Christian Dowdeswell |
| Consejo de supervisión |
| Dr. Andreas Casutt, Alexandra Brand, Beat Walti, Dr. Martin Schmid, Isabelle Welton, Wolfram Carius, Elodie Carr-Cingari |
Datos de la empresa
| Nombre: |
Siegfried Holding AG |
| Dirección: |
Untere Brühlstraße 4,CH-4800 Zofingen |
| Teléfono: |
+41-62-746-1111 |
| Fax: |
+41-62-746-1202 |
| E-mail: |
info@siegfried.ch
|
| Internet: |
www.siegfried.ch |
| Industria: |
Commodities |
| Sector: |
Chemicals |
| Subsector: |
- |
| Fin del año financiero: |
31/12 |
| Acciones de libre circulación: |
75.10% |
| Fecha de OPI: |
- |
Relación con inversores
| Nombre: |
Reto Suter |
| IR teléfono: |
+41-62-746-15-35 |
| IR-fax: |
- |
| IR e-mail: |
reto.suter@siegfried.ch
|
